Search Symbol

Most Active Stocks

NIACL

HDFCBANK

DMART

VBL

TATAMOTORS

ICICIBANK

JAYNECOIND

RELIANCE

BHARTIARTL

EBGNG

AXISBANK

TCS

INFY

WAAREEENER

AMBER

KOTAKBANK

M&M

SBIN

INDIGO

Kopran Limited

Drug Manufacturers - General | Healthcare

Company Overview

Kopran Limited, an integrated pharmaceutical company, engages in the manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-acne, anti-infective, anti-thrombotic, antidiabetic, pain management, neuromodular, gastroenterology, and cardiovascular. In addition, the company provides drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is based in Mumbai, India.

Key Information

Market Cap

8659110912

Current Price

177.02

52 Week Range

155.0 - 369.7

Previous Close

178.47

Open

177.61

Industry

Drug Manufacturers - General

Sector

Healthcare

Contact Details

Address

Parijat House, 1076, Dr. E. Moses Road Worli, Mumbai, 400018, India

Phone

+91-22436-61111

Fax

+91-22249-50363

Website

https://www.kopran.com

Financials

Day Low

176.0

Day High

179.48

Dividend Yield

1.68

PE Ratio

22.1275

Earnings Per Share

8.0

Beta

0.544

EBITDA

728998976

Book Value

107.662

EPS

Company Officers

Name	Title	Age	Year Born
Mr. Surendra Shrikrishna Somani B.Com.	Executive Vice Chairman & MD	70	1954
Mr. Basant Kumar Soni	Chief Financial Officer	-	-
Mr. Sunil Sodhani	Company Secretary & Compliance Officer	-	-
Mr. Ajit Jain FCA	Chief Operating Officer	63	1961
Ms. Vandana Somani	Director	-	-